U.S. Physical Therapy, Inc. (USPH)

Full history for every metric is available with a Kvantra account

Stock profile
U.S. Physical Therapy, Inc. logo

U.S. Physical Therapy, Inc. (USPH)

Country: United States of AmericaSector: HealthcareIndustry: Medical - Care FacilitiesExchange: NYSE
P/E TTM
506.4
History
P/E NTM
N/A
Market cap
1.29B
Currency USD
KvantraRankAbout60
IValue91
IIQuality43
IIIMomentum36
Current price
86.09 USD+1.47%
Benchmarks

No price history available.

Key financial summary

Financials in USD
202020212022202320242025TTM2026E
Total revenue$m423495553605671781779848
Operating profit$m8084
Net profit$m312828152615-645
EPS reported$1.420.17
Operating cashflow per share$4.955.51
Capex per share$0.931.26
FCF per share$4.024.25
Free cash flow$m6164
Net debt$m280195
Book value equity$m476449
Book value per share$31.4029.77
Number of sharesm15.1815.07
DPS (TTM paid)$1.801.83

Financial summary

Financials in USD
202020212022202320242025TTM2026E
Value
P/E TTMx54.99506.41
P/B LTMx2.492.64
P/S LTMx1.521.52
P/FCF LTMx19.4318.50
EV/EBITDA LTMx14.3615.71
EV/Sales LTMx2.021.78
Earnings Yield LTM%+1.82%+0.20%
FCF Yield%+5.15%+5.41%
Quality
ROE%+3.16%+0.48%
ROIC%+5.37%+5.25%
Operating margin%+10.30%+10.81%
Gross margin%+20.15%+19.17%
FCF/Sales%+7.81%+8.22%
Growth and momentum
EPS Growth YoY%-22.83%-90.76%
Sales Growth YoY%+16.33%+16.05%
Net Income Growth YoY%-43.08%-
FCF Growth%-7.25%-2.56%
Operating Profit Growth%+27.24%+33.25%
Dividend and capital structure
Dividend Yield%+2.31%+2.24%
Dividend Growth%+2.27%+3.98%
Payout Ratio%+126.98%+1069.6%
FCF/Debtx0.140.17
Net Debt/EBITDAx3.561.46
EBIT/Net interestx8.507.83
Net debt/market cap%+26.60%+13.82%
Net debt/Equityx0.590.43
Gross debt/equityx0.890.86

Price target estimates

Low estimate
High estimate
Price consensus
Last year average price target
Current price86.09 USD
Return Potential

Based on consensus from external analysts. Not Kvantra's opinion.

Ratings

Strong Buy
Buy
Hold
Sell
Strong Sell
Number of covering analysts

Based on consensus from external analysts. Not Kvantra's opinion.

ESG

Metric202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating

Company overview

U.S. Physical Therapy, Inc., through its various subsidiaries, manages a network of outpatient physical therapy facilities. These clinics deliver a range of services, including rehabilitation before and after surgery, treatment for musculoskeletal conditions, recovery from sports-related trauma, proactive health measures, assistance for workers recovering from injuries, and care for neurological conditions. The company's business is divided into two primary divisions: Physical Therapy Operations and Industrial Injury Prevention Services. Within its industrial segment, it provides specialized services like on-site injury avoidance and recovery programs, strategies for enhancing physical performance, pre-employment screening tests, assessments of an individual's work capacity, and workplace ergonomic reviews. These offerings are delivered by licensed physical therapists and expert certified athletic trainers to a diverse clientele, including Fortune 500 corporations, insurance providers, and their associated contractors. By the end of 2021, specifically December 31st, the company had established 591 operational clinics across 39 states, in addition to overseeing 35 other physical therapy sites. Established in 1990, the company maintains its headquarters in Houston, Texas.

Websiteusph.com
SectorHealthcare
IndustryMedical - Care Facilities
CountryUnited States of America
Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

U.S. Physical Therapy, Inc. (USPH)

USPH · NYSE · Healthcare
86.09 USD+1.47%
Sign up to track this stock

No price history available.

KvantraRank60
Market cap1.29B
P/E NTMN/A
P/E TTM506.4
KvantraRank?60 / 100
Value
91
Quality
43
Momentum
36
Financialsin USD
20242025TTM2026E
Analyst target
Consensus
Current86.09 USD
Upside
Price consensus
Last year average price target
Current price86.09 USD
Return Potential

Consensus from external analysts. Not Kvantra's opinion.

Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Based on consensus from external analysts. Not Kvantra's opinion.

ESG
202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating
About

U.S. Physical Therapy, Inc., through its various subsidiaries, manages a network of outpatient physical therapy facilities. These clinics deliver a range of services, including rehabilitation before and after surgery, treatment for musculoskeletal conditions, recovery from sports-related trauma, proactive health measures, assistance for workers recovering from injuries, and care for neurological conditions. The company's business is divided into two primary divisions: Physical Therapy Operations and Industrial Injury Prevention Services. Within its industrial segment, it provides specialized services like on-site injury avoidance and recovery programs, strategies for enhancing physical performance, pre-employment screening tests, assessments of an individual's work capacity, and workplace ergonomic reviews. These offerings are delivered by licensed physical therapists and expert certified athletic trainers to a diverse clientele, including Fortune 500 corporations, insurance providers, and their associated contractors. By the end of 2021, specifically December 31st, the company had established 591 operational clinics across 39 states, in addition to overseeing 35 other physical therapy sites. Established in 1990, the company maintains its headquarters in Houston, Texas.

Websiteusph.com
SectorHealthcare
IndustryMedical - Care Facilities
CountryUnited States of America
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free